Chemiluminescent transition metal complexes: Mechanisms and applications
Jinghui Zhu,
No information about this author
Mingrui Gu,
No information about this author
Yahui Chen
No information about this author
et al.
Coordination Chemistry Reviews,
Journal Year:
2025,
Volume and Issue:
530, P. 216495 - 216495
Published: Feb. 5, 2025
Language: Английский
Advances in phototheranostic agents: From imaging to targeted therapy
Materials Today Chemistry,
Journal Year:
2025,
Volume and Issue:
43, P. 102516 - 102516
Published: Jan. 1, 2025
Language: Английский
Advanced strategies in the design of Ir(III) biscyclometalated complexes for PDT
Coordination Chemistry Reviews,
Journal Year:
2025,
Volume and Issue:
534, P. 216572 - 216572
Published: March 14, 2025
Language: Английский
Synergistic Comprehensive Activation Methods for Dual‐Modality PDT and Hypoxia‐Triggered Chemotherapy Guided by NIR‐II Imaging beyond 1700 nm in Deep Tumors
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 8, 2025
Abstract
Although
photodynamic
therapy
(PDT)
holds
great
promise
for
applications
in
cancer
treatment,
it
has
limited
effectiveness
against
deep
hypoxic
tumors.
Moreover,
the
lack
of
visualization
guidance
precision
theranostics
poses
additional
challenges,
hindering
its
broader
clinical
adoption.
By
combining
NIR‐IIc
(1800
nm)
imaging
with
internally
and
externally
activatable
dual‐modality
PDT
hypoxia‐triggered
chemotherapy,
this
study
proposes
a
conceptual
framework
to
overcome
these
limitations.
This
approach
involves
use
photoswitchable
lanthanide‐doped
nanoparticles
featuring
Tm
3+
‐activated
upconversion/downshifting
emissions
coupled
carboxyl‐terminated
Ir(III)
complex‐based
Type
I/II
photosensitizer
form
nanophotosensitizer.
The
findings
demonstrate
that
system
enabled
upon
808/980
nm
excitation
while
selectively
activating
external
under
980
irradiation,
thereby
ensuring
accurate
minimizing
phototoxicity
risk.
complex
conjugates
luminol
self‐illuminating
photosensitizer,
which
can
respond
elevated
H
2
O
levels
tumor
microenvironment,
effectively
catalyzing
chemiluminescence‐assisted
PDT.
aggravates
hypoxia,
turn
activates
hypoxia‐activatable
prodrugs
like
tirapazamine,
resulting
synergistic
antitumor
effect.
With
imaging‐guided
PDT,
introduces
groundbreaking
unites
significantly
advancing
precise
effective
treatment
Language: Английский
Disulfide-Bridged Cationic Dinuclear Ir(III) Complex with Aggregation-Induced Emission and Glutathione-Consumption Properties for Elevating Photodynamic Therapy
Meijia Huang,
No information about this author
Jie Cui,
No information about this author
Qi Wu
No information about this author
et al.
Inorganic Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 2, 2024
The
ability
of
photosensitizers
(PSs)
to
generate
reactive
oxygen
species
(ROS)
is
crucial
for
photodynamic
therapy
(PDT).
However,
many
traditional
PSs
face
the
drawbacks
that
aggregation-caused
quenching
(ACQ)
and
highly
expressed
glutathione
(GSH)
in
tumor
microenvironment
seriously
limit
their
ROS
generation
ability.
Herein,
we
report
two
cationic
dinuclear
iridium
complexes,
Ir–C–C–Ir
Ir–S–S–Ir,
which
possess
aggregation-induced
emission
(AIE).
Ir–S–S–Ir
was
constructed
GSH
consumption
by
introducing
a
disulfide
linkage
between
auxiliary
ligands
with
imine
units.
Quantum
chemical
calculations
revealed
degenerate
states,
provide
more
channels
singlet-to-triplet
exciton
transitions,
then
intersystem
crossing
rate
increased
due
heavy
atom
effect
sulfur
atoms.
production
experiments
indicated
singlet
yield
33
times
than
ACQ
mononuclear
complex
Ir–C.
Most
importantly,
consumed
through
thiol–disulfide
exchange
reaction,
as
demonstrated
mass
spectrometry
high-performance
liquid
chromatography.
Cell
testified
consumes
cells,
possesses
good
capacity,
exhibits
an
extraordinary
PDT
effect.
This
first
AIE
GSH-consuming
function.
Language: Английский